Citation Impact
Citing Papers
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Normal gut microbiota modulates brain development and behavior
2011 Standout
The Role of Innate and Adaptive Immunity in Parkinson's Disease
2013
Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators
2006 Standout
Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease
2006
Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease
2008
Effects of Hydrogen Sulfide-releasing l-DOPA Derivatives on Glial Activation
2010
Astrocytes: biology and pathology
2009 Standout
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Inflammation and neurodegeneration in Parkinson's disease
2004
Toxin-induced models of Parkinson’s disease
2005
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
2020 Standout
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
2009 Standout
Parkinson disease
2017 Standout
Human Interleukin-10 Gene Transfer Is Protective in a Rat Model of Parkinson's Disease
2008
Microglia: active sensor and versatile effector cells in the normal and pathologic brain
2007 Standout
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease.
2004
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
2008
Increased host neuronal survival and motor function in BMT Parkinsonian mice: Involvement of immunosuppression
2007
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Pathological roles of MAPK signaling pathways in human diseases
2010 Standout
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
2005
Microglial activation and dopamine terminal loss in early Parkinson's disease
2005
Structure and function of the blood–brain barrier
2009 Standout
Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study
2011
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders
2008
Microglia and neuroprotection: From in vitro studies to therapeutic applications
2010
Microglial cell origin and phenotypes in health and disease
2011 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
2014
Epidemiology of Parkinson's disease
2006 Standout
Mitochondria Are a Major Source of Paraquat-induced Reactive Oxygen Species Production in the Brain
2007 Standout
Glial reactions in Parkinson's disease
2007
Neuroinflammatory processes in Parkinson's disease
2005
Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus)
1997
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
2005
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
Air pollution: mechanisms of neuroinflammation and CNS disease
2009 Standout
Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms
2019
Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease
2008
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
The executioners sing a new song: killer caspases activate microglia
2011
Animal models of Parkinson’s disease progression
2008
Neural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease
2013
Parkinson's disease
2015 Standout
Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord
2009 Standout
Inflammation, the complement system and the diseases of aging
2005
Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
2008
Genomic Analysis of Reactive Astrogliosis
2012 Standout
Immunological features of α‐synuclein in Parkinson's disease
2008
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease
2013
Inflammation as a causative factor in the aetiology of Parkinson's disease
2007
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B
2008
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
2007 Standout
Inflammation and the Degenerative Diseases of Aging
2004
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
2007
Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsy
2011
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Reactive Astrocytes: Production, Function, and Therapeutic Potential
2017 Standout
Parkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration
2008
Interactive role of the toll‐like receptor 4 and reactive oxygen species in LPS‐induced microglia activation
2005
Etiology and pathogenesis of Parkinson's disease
2011
Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1β in the substantia nigra
2006
The Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis
2017
Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
2013
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Peripheral Inflammatory Biomarkers and Risk of Parkinson's Disease
2007
Hydrogen sulfide‐releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation
2009
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson’s disease
2006
Innate and Adaptive Immunity for the Pathobiology of Parkinson's Disease
2009
Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
2012 Standout
Neuroinflammation: the devil is in the details
2016 Standout
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling
2011 Standout
Transcriptional Factor NF-κ
2011
Neuroimmunological Processes in Parkinson’s Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral Immunity
2013
Microglia-Mediated Neurotoxicity Is Inhibited by Morphine through an Opioid Receptor-Independent Reduction of NADPH Oxidase Activity
2007
Regulation of astrocyte inflammatory responses by the Parkinson's disease‐associated gene DJ–1
2009
Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease
2009
Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinsons Disease
2007
Chronic microglial activation and progressive dopaminergic neurotoxicity
2007
Hepatitis C virus infection: a risk factor for P arkinson's disease
2015
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
Long oligonucleotide microarrays for African green monkey gene expression profile analysis
2007 StandoutNobel
Neuroinflammation and Peripheral Immune Infiltration in Parkinson's Disease: An Autoimmune Hypothesis
2008
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Blood–Brain Barrier Pathology in Alzheimer's and Parkinson's Disease: Implications for Drug Therapy
2007
Exosomes as drug delivery vehicles for Parkinson's disease therapy
2015 Standout
Microglial M1/M2 polarization and metabolic states
2015 Standout
Alpha‐synuclein and its disease‐causing mutants induce ICAM‐1 and IL‐6 in human astrocytes and astrocytoma cells
2006
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
Physiology of Microglia
2011 Standout
Works of Doris Doudet being referenced
Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys
2005
Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administration
2003
Effect of increasing regimens of levodopa on chronic MPTP-induced parkinsonism in monkey; mechanographic and electromyographic data.
1986